These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 22087000)
1. Discovery of deoxyceramides and diacylglycerols as CD1b scaffold lipids among diverse groove-blocking lipids of the human CD1 system. Huang S; Cheng TY; Young DC; Layre E; Madigan CA; Shires J; Cerundolo V; Altman JD; Moody DB Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19335-40. PubMed ID: 22087000 [TBL] [Abstract][Full Text] [Related]
2. The CD1 size problem: lipid antigens, ligands, and scaffolds. Ly D; Moody DB Cell Mol Life Sci; 2014 Aug; 71(16):3069-79. PubMed ID: 24658584 [TBL] [Abstract][Full Text] [Related]
3. The molecular basis of CD1-mediated presentation of lipid antigens. Moody DB; Besra GS; Wilson IA; Porcelli SA Immunol Rev; 1999 Dec; 172():285-96. PubMed ID: 10631954 [TBL] [Abstract][Full Text] [Related]
4. Lipid-protein interactions: biosynthetic assembly of CD1 with lipids in the endoplasmic reticulum is evolutionarily conserved. Park JJ; Kang SJ; De Silva AD; Stanic AK; Casorati G; Hachey DL; Cresswell P; Joyce S Proc Natl Acad Sci U S A; 2004 Jan; 101(4):1022-6. PubMed ID: 14722359 [TBL] [Abstract][Full Text] [Related]
5. The intricacies of self-lipid antigen presentation by CD1b. Shahine A Mol Immunol; 2018 Dec; 104():27-36. PubMed ID: 30399491 [TBL] [Abstract][Full Text] [Related]
6. Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains. Gadola SD; Zaccai NR; Harlos K; Shepherd D; Castro-Palomino JC; Ritter G; Schmidt RR; Jones EY; Cerundolo V Nat Immunol; 2002 Aug; 3(8):721-6. PubMed ID: 12118248 [TBL] [Abstract][Full Text] [Related]
14. Endogenous phosphatidylcholine and a long spacer ligand stabilize the lipid-binding groove of CD1b. Garcia-Alles LF; Versluis K; Maveyraud L; Vallina AT; Sansano S; Bello NF; Gober HJ; Guillet V; de la Salle H; Puzo G; Mori L; Heck AJ; De Libero G; Mourey L EMBO J; 2006 Aug; 25(15):3684-92. PubMed ID: 16874306 [TBL] [Abstract][Full Text] [Related]
15. Four pathways of CD1 antigen presentation to T cells. Moody DB; Cotton RN Curr Opin Immunol; 2017 Jun; 46():127-133. PubMed ID: 28756303 [TBL] [Abstract][Full Text] [Related]
16. Diverse antigen presentation by the Group 1 CD1 molecule, CD1c. Adams EJ Mol Immunol; 2013 Sep; 55(2):182-5. PubMed ID: 23127489 [TBL] [Abstract][Full Text] [Related]
17. The crystal structure of human CD1b with a bound bacterial glycolipid. Batuwangala T; Shepherd D; Gadola SD; Gibson KJ; Zaccai NR; Fersht AR; Besra GS; Cerundolo V; Jones EY J Immunol; 2004 Feb; 172(4):2382-8. PubMed ID: 14764708 [TBL] [Abstract][Full Text] [Related]
18. Do antigen-presenting CD1a, CD1b, CD1c, and CD1d molecules bind different self-lipids? Van Rhijn I Trends Immunol; 2023 Oct; 44(10):757-759. PubMed ID: 37730500 [TBL] [Abstract][Full Text] [Related]
19. Expression patterns of bovine CD1 in vivo and assessment of the specificities of the anti-bovine CD1 antibodies. Nguyen TK; Reinink P; El Messlaki C; Im JS; Ercan A; Porcelli SA; Van Rhijn I PLoS One; 2015; 10(3):e0121923. PubMed ID: 25815476 [TBL] [Abstract][Full Text] [Related]
20. Molecular features of lipid-based antigen presentation by group 1 CD1 molecules. Le Nours J; Shahine A; Gras S Semin Cell Dev Biol; 2018 Dec; 84():48-57. PubMed ID: 29113870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]